TrademarkDir
NUCLEAR DELIVERY PLATFORM
DEAD

Serial Number

88730049

Owner

Angiex, Inc.

Attorney

Susanna P. Lichter

Filing Date

Dec 17, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

NUCLEAR DELIVERY PLATFORM Trademark

Serial Number: 88730049

NUCLEAR DELIVERY PLATFORM is a trademark filed by Angiex, Inc. on December 17, 2019. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Angiex, Inc. (8 trademarks)

393 Broadway, #15
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

December 17, 2019

Registration Date

Not Registered

Goods & Services

Scientific research and development in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; research and product development services for others in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; Medical and scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease detection; Providing information on the subject of scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 7, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 6, 2022 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 1, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 1, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 1, 2021 CNRT
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Aug 31, 2021 AAUA
USE AMENDMENT ACCEPTED
Aug 29, 2021 IUAA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 6, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 6, 2021 CRFA
AMENDMENT TO USE PROCESSING COMPLETE
Aug 6, 2021 AUPC
USE AMENDMENT FILED
Aug 6, 2021 IUAF
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 6, 2021 ERFR
TEAS AMENDMENT OF USE RECEIVED
Aug 5, 2021 EAAU
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 10, 2021 GNFN
FINAL REFUSAL E-MAILED
Feb 10, 2021 GNFR
FINAL REFUSAL WRITTEN
Feb 10, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 23, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2021 CRFA
ASSIGNED TO LIE
Jan 23, 2021 ALIE
NOTICE OF REVIVAL - E-MAILED
Oct 13, 2020 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 12, 2020 TROA
PETITION TO REVIVE-GRANTED
Oct 12, 2020 PETG
TEAS PETITION TO REVIVE RECEIVED
Oct 12, 2020 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 1, 2020 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 1, 2020 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 17, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 17, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 17, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 16, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 20, 2019 NWOS
NEW APPLICATION ENTERED
Dec 20, 2019 NWAP

Related Trademarks

More from this Owner

Trademark logo

Serial #98503129

Trademark logo

Serial #98503129

Trademark logo

Serial #98503129

NUCLEAR DELIVERY PLATFORM

NUCLEAR DELIVERY PLATFORM

NUCLEAR DELIVERY PLATFORM

NUCLEAR DELIVERY PLATFORM

NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES

NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES